Synthesis and antiviral activity of purine 2',3'-dideoxy-2',3'-difluoro-D-arabinofuranosyl nucleosides. 2009

Grigorii G Sivets, and Elena N Kalinichenko, and Igor A Mikhailopulo, and Mervi A Detorio, and Tami R McBrayer, and Tony Whitaker, and Raymond F Schinazi
Institute of Bioorganic Chemistry, National Academy of Sciences, Minsk, Belarus.

9-(2',3'-Dideoxy-2',3'-difluoro-beta-D-arabinofuranosyl)adenine (20), 2-chloro-9-(2',3'-dideoxy-2,3-difluoro-beta-D-arabinofuranosyl)adenine (22), as well as their respective alpha-anomers 21 and 23, were synthesized by the nucleobase anion glycosylation of intermediate 5-O-benzoyl-2,3-dideoxy-2,3-difluoro-alpha-D-arabinofuranosyl bromide (13) starting from methyl 5-O-benzyl-3-deoxy-3-fluoro-alpha-D-ribofuranoside (3) and methyl 5-O-benzoyl-alpha-D-xylofuranoside (10). These compounds were evaluated as potential inhibitors of HIV-1 and hepatitis C virus in human PBM and Huh-7 Replicon cells, respectively. The adenosine analog 20 demonstrated potent activity against HIV-1 in primary human lymphocytes with no apparent cytotoxicity. Conformation of pentofuranose ring of nucleoside 20 in solution was studied by PSEUROT calculations.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011684 Purine Nucleosides Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES. Purine Nucleoside,Nucleoside, Purine,Nucleosides, Purine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Grigorii G Sivets, and Elena N Kalinichenko, and Igor A Mikhailopulo, and Mervi A Detorio, and Tami R McBrayer, and Tony Whitaker, and Raymond F Schinazi
January 2015, Heterocyclic communications,
Grigorii G Sivets, and Elena N Kalinichenko, and Igor A Mikhailopulo, and Mervi A Detorio, and Tami R McBrayer, and Tony Whitaker, and Raymond F Schinazi
March 2019, Tetrahedron,
Grigorii G Sivets, and Elena N Kalinichenko, and Igor A Mikhailopulo, and Mervi A Detorio, and Tami R McBrayer, and Tony Whitaker, and Raymond F Schinazi
January 2003, Nucleosides, nucleotides & nucleic acids,
Grigorii G Sivets, and Elena N Kalinichenko, and Igor A Mikhailopulo, and Mervi A Detorio, and Tami R McBrayer, and Tony Whitaker, and Raymond F Schinazi
January 2001, Nucleosides, nucleotides & nucleic acids,
Grigorii G Sivets, and Elena N Kalinichenko, and Igor A Mikhailopulo, and Mervi A Detorio, and Tami R McBrayer, and Tony Whitaker, and Raymond F Schinazi
September 1972, Journal of medicinal chemistry,
Grigorii G Sivets, and Elena N Kalinichenko, and Igor A Mikhailopulo, and Mervi A Detorio, and Tami R McBrayer, and Tony Whitaker, and Raymond F Schinazi
January 1999, Nucleosides & nucleotides,
Grigorii G Sivets, and Elena N Kalinichenko, and Igor A Mikhailopulo, and Mervi A Detorio, and Tami R McBrayer, and Tony Whitaker, and Raymond F Schinazi
January 2001, Nucleic acids research. Supplement (2001),
Grigorii G Sivets, and Elena N Kalinichenko, and Igor A Mikhailopulo, and Mervi A Detorio, and Tami R McBrayer, and Tony Whitaker, and Raymond F Schinazi
October 2010, Bioorganic & medicinal chemistry letters,
Grigorii G Sivets, and Elena N Kalinichenko, and Igor A Mikhailopulo, and Mervi A Detorio, and Tami R McBrayer, and Tony Whitaker, and Raymond F Schinazi
June 2005, Journal of medicinal chemistry,
Grigorii G Sivets, and Elena N Kalinichenko, and Igor A Mikhailopulo, and Mervi A Detorio, and Tami R McBrayer, and Tony Whitaker, and Raymond F Schinazi
January 1990, Journal of medicinal chemistry,
Copied contents to your clipboard!